[AVTE] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[AVTE] Aerovate Therapeutics, Inc.
Announcement Date
30-Mar-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- -32.97%
YoY- -124.30%
Quarter Report
AVTE's Result
AVTE's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -13,588 -11,991 -10,910 -8,220 -6,184 -5,775 -2,781 187.66%
Tax -564 -224 -109 3 0 -2 -1 6700.05%
NP -13,024 -11,767 -10,801 -8,223 -6,184 -5,775 -2,781 179.65%
Tax Rate - - - - - - - -
Total Cost 13,024 11,767 10,801 8,223 6,184 5,775 2,781 179.65%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS -0.53 -0.48 -0.44 -0.34 -0.26 -23.76 -0.13 154.98%
EPS Diluted -0.53 -0.48 -0.44 -0.34 -0.26 -23.76 -0.13 154.98%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.